logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Parkinson Disease

    FiltersReset Filters
    30 results

    • amantadine

      (amantadine)
      Alembic Pharmaceuticals Inc.
      Usage: Amantadine hydrochloride capsules are indicated for prophylaxis and treatment of influenza A virus infections and for treating parkinsonism and drug-induced extrapyramidal reactions. They are recommended during influenza outbreaks and in patients exhibiting parkinsonism symptoms, although they are less effective than some other treatments for Parkinson's disease.

    • amantadine hcl

      (AMANTADINE HYDROCHLORIDE)
      Bionpharma Inc.
      Usage: Amantadine Hydrochloride Capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for managing parkinsonism and drug-induced extrapyramidal reactions. Prophylaxis assists immune response development, but it’s not a substitute for vaccination. Effectiveness for other viral illnesses is not established.

    • amantadine hydrochloride

      (Amantadine Hydrochloride)
      Advagen Pharma Limited
      Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and is less effective than levodopa for Parkinson's disease.

    • azilect

      (Rasagiline mesylate)
      Teva Neuroscience, Inc.
      Usage: AZILECT (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).

    • bromocriptine mesylate

      (Bromocriptine mesylate)
      Zydus Pharmaceuticals USA Inc.
      Usage: Bromocriptine mesylate capsules are indicated for treating hyperprolactinemia-related disorders (e.g., amenorrhea, infertility, hypogonadism), acromegaly, and symptoms of Parkinson's disease. It may be used with levodopa to enhance efficacy and reduce side effects, especially in patients experiencing tolerance or "end of dose failure."

    • bromocriptine mesylate

      (Bromocriptine mesylate)
      Sandoz Inc
      Usage: Bromocriptine mesylate tablets are indicated for treating hyperprolactinemia-related dysfunctions (e.g., amenorrhea, infertility), acromegaly, and symptoms of Parkinson's disease. They help reduce tumor size in prolactin-secreting adenomas and enhance effects of levodopa in Parkinson's, while potentially reducing levodopa dosage and adverse reactions.

    • carbidopa and levodopa

      (Carbidopa and Levodopa)
      Alembic Pharmaceuticals Limited
      Usage: Carbidopa and levodopa extended-release tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.

    • carbidopa and levodopa

      (Carbidopa and Levodopa)
      Dr. Reddy's Laboratories Inc.
      Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism from carbon monoxide or manganese intoxication. They improve response to levodopa, reduce necessary dosing, and may decrease nausea, allowing for faster dose adjustments.

    • carbidopa and levodopa

      (Carbidopa and levodopa)
      Advagen Pharma Ltd
      Usage: Carbidopa and levodopa extended-release tablets are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism symptoms resulting from carbon monoxide or manganese intoxication.

    • carbidopa and levodopa

      (CARBIDOPA AND LEVODOPA)
      Sun Pharmaceutical Industries, Inc.
      Usage: Carbidopa and levodopa orally disintegrating tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism after carbon monoxide or manganese intoxication. They allow lower levodopa doses, improve some patients' responses, reduce nausea, and facilitate faster titration of levodopa.